Trials / Completed
CompletedNCT05353725
Extracorporeal Membrane Oxygenation in Coronavirus Disease (COVID-19), Influenza and ARDS of Other Ethiologies
Extracorporeal Membrane Oxygenation in COVID-19, Influenza and ARDS of Other Ethiologies
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- University Medical Centre Ljubljana · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A comparison of clinical characteristics and outcomes of patients on extracorporeal membrane oxygenation (ECMO) in COVID-19, influenza and ARDS of other ethiologies
Detailed description
All ARDS patients on extracorporeal membrane oxygenation (ECMO) during January 1st 2016 and January 10th 2022 in University Medical Center Ljubljana were included and their clinical characteristics and outcomes were studied according to ARDS ethiology: COVID-19, influenza and other ethiologies.
Conditions
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2022-02-10
- Completion
- 2022-03-01
- First posted
- 2022-04-29
- Last updated
- 2022-05-05
Source: ClinicalTrials.gov record NCT05353725. Inclusion in this directory is not an endorsement.